Yahoo! Inc. (YHOO) reported fourth quarter EPS of $0.13 after the closing bell Tuesday, in-line with the consensus estimates. Revenues declined 15% from $1.18 billion last year to $1.00 billion. Analysts expected revenues of $948.02 million. Yahoo also said it is exploring strategic alternatives for the company’s beleaguered Web business while slashing staff by about 15 percent. The stock is currently down $0.11 to $28.95 on 34.11 million shares.
Shares of Fiserv, Inc. (FISV) are flat to $93.04 in extended-hours after the provider of financial services technology reported fourth-quarter earnings of $1.37 billion, or $1.00 per share. Analysts had been modeling $1.40 billion and $1.00 per share.
For full fiscal year 2016, FISV provided EPS guidance of $4.32-$4.44 – which would represent growth of 12 to 15% over $3.87 in 2015 – versus consensus of $4.33 per share.
Gilead Sciences Inc. (GILD) gained $0.78 to $83.48 in after-hours trading after it reported 2015 fourth-quarter earnings.
The Foster City, California-based biopharmaceutical company handed in earnings of $3.32 per share on revenue of $8.51 billion, beating Wall Street estimates of $2.98 per share on revenue of $8.16 billion.
GILD currently prints a one year loss of 21.19% and a year-to-date loss of 18.27%.
Illumina Inc. (ILMN) shares are down $0.66 to $154.00 in after-hours trading Tuesday after the company reported its fourth quarter earnings results.
San Diego, California-based firm reported earnings of $0.81 per share on revenues of $591.55 million, up 15.5% from a year ago. Analysts were expecting EPS of $0.82 on revenues of $586.94 million.
For FY16, ILMN provided EPS guidance of $3.55-$3.65 versus consensus of $3.64 per share.
Qiagen NV (QGEN) reported fiscal results for the fourth quarter.
In its quarterly report, the Netherlands-based holding company said it earned $0.31 per share, below the $0.32 per share analysts were expecting. Revenue fell 3.4% to $348.5 million, below views for $350.99 million.
For Q116, Qiagen provided EPS guidance of $0.19-$0.20 versus consensus of $0.23 per share. The company also issued revenue projection of $304 million, compared to the consensus revenue estimate of $307.67 million.